Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 563 (LINC00563) is a human gene located on chromosome 13 (13q14.11) that encodes a long non-coding RNA (lncRNA); this RNA does not code for a protein and is classified within the lncRNA family[1][3][5][6][7]. Its functional roles, implication in disease, and potential as a therapeutic target are not established in the scientific literature or major genomic databases; there is no evidence of interaction with drugs, no known mechanism of action relevant to therapy, and it is not recognized as a biomarker for patient selection or efficacy monitoring[5][6][7]. Currently, LINC00563 is annotated primarily as a genomic locus with long non-coding RNA transcription, with no direct evidence for involvement in canonical biological processes, molecular pathways, or pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 563 (LINC00563).